Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
4 DSLR Cameras for Amateurs in 2024 - 2My Excursion to Monetary Autonomy: Awesome ways to save cash
- 3Danish warship sunk by famed British admiral discovered after 225 years
- 4Two IDF officers, civilian face indictment in alleged Gaza aid-truck smuggling scheme
- 5Arctic is again the hottest it's been in 125 years, with record-low sea ice, NOAA report says
- Paris Agreement target off the table, report says
- 5 Pizza Fixings That Characterize Your Character
- From Exemplary to Current: Famous Rings Available
- Sources: IDF does not actually know how many ballistic missiles Iran has left
- Architect Frank Gehry has died: See his most iconic buildings
- Instructions to Amplify Certifiable Experience While Chasing after an Internet Advertising Degree
- Japan prepares to restart world's biggest nuclear plant, 15 years after Fukushima
- Tech giants accused of not complying with Australian social media ban
- Step by step instructions to Get a good deal on Your Rooftop Substitution Venture
